🇫🇮 AMPlify boosts Finnish health tech into the U.S. market

Business Finland has established a significant collaboration model with the U.S.-based hospital system, Mayo Clinic, a global leader in the health sector. This collaboration is opening doors for Finland’s most promising health technology solutions providing them access to key stakeholders in the U.S. healthcare ecosystem. At the heart of this collaboration is the AMPlify accelerated market entry platform, addressing the specific needs of Finnish health tech companies.

Evolving from Kasvu and Gazelli, AMPlify was designed by former BF’er Val Kratzman to integrate Finnish healthcare solutions with US market needs.

Tailored support for Finnish Health Tech companies

AMPlify expedites Finnish health technology companies’ entry into the vast U.S. market. The first cohort included 12 Finnish companies. Throughout the fall, Business Finland hosted bi-weekly virtual workshops, during which industry experts provided training on U.S. market regulatory processes, market entry strategies, and local business practices.

Knowledge and Networking at Mayo Clinic

In November, the program culminated in Finnish companies visiting Mayo Clinic’s headquarters in Minnesota. During the visit, the companies met with experts and Mayo Clinic executives to explore collaboration opportunities. Additionally, they were invited to attend an exclusive invitation-only seminar to network with investors and strategists.

This collaboration with Mayo Clinic offers Finnish companies excellent opportunities for market entry.

Titta Houni, Senior Advisor for Health and Wellbeing at Business Finland’s New York office, highlighted that this collaboration with Mayo Clinic offers Finnish companies excellent opportunities for market entry.

“Mayo Clinic’s mission is to deliver the best healthcare and innovations globally, always putting the patient at the center. Co-development is the key to collaboration with Mayo Clinic, and the organization is committed to this even beyond the U.S. borders. This is not a given, as U.S. hospitals often favor domestic collaboration. During the AMPlify, the companies gained valuable direct contacts, co-innovation opportunities, and insights into the U.S. market and business landscape. By connecting Finnish innovation with one the leading hospitals in the U.S., Business Finland and Mayo Clinic are paving the way for impactful collaborations, improving healthcare outcomes worldwide,” said Houni.

Adamant Health targets the U.S. Market

One of the companies selected for the AMPlify is Adamant Health. The company’s mission is to revolutionize the treatment of Parkinson’s disease by providing precise and objective data on patients’ symptoms in their home environment.

“Although the U.S. has only one-tenth of the world’s Parkinson’s patients, nearly half of the global treatment costs for Parkinson’s disease are incurred there. Therefore, it is clear that Adamant Health must enter the U.S. market. The AMPlify provided a strong foundation for beginning this journey,” said Adamant Health CEO Paulus Carpelan.

All sessions featured carefully selected, experienced experts who shared valuable firsthand insights.

“In the program, we participated in several educational and workshop events, primarily online. These covered a wide range of topics on entering the U.S. health tech market, including crafting a value proposition, adapting products or services to the U.S. market, regulatory processes for medical devices, reimbursement practices, and conducting clinical trials. All sessions featured carefully selected, experienced experts who shared valuable firsthand insights,” Carpelan added.

Business Finland’s Support for Adamant Health

“Business Finland has been a key partner for Adamant Health as we have built and advanced the company step by step. Business Finland’s support, expertise, and networks have been instrumental in securing funding, creating relevant contacts, and fostering international networking. Their support has been both practical and hands-on, and open discussions have helped identify timely and impactful solutions for the company,” Carpelan praised.

AMPlify is part of Business Finland’s Health 360 Finland program and will continue in 2025.

Further Information 

Titta Houni
Senior Advisor, Health & Wellbeing
Business Finland New York
titta.houni (at) businessfinland.fi

Originally published on 27 November by Business Finland.

Announcements are published as a service to readers. The sender is responsible for all content.

Announcements for publication can be submitted to [email protected].